GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Forza Innovations Inc (OTCPK:FORZ) » Definitions » Peter Lynch Fair Value

Forza Innovations (Forza Innovations) Peter Lynch Fair Value : N/A (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Forza Innovations Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Forza Innovations's Peter Lynch Fair Value or its related term are showing as below:



FORZ's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.71
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Forza Innovations Peter Lynch Fair Value Historical Data

The historical data trend for Forza Innovations's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forza Innovations Peter Lynch Fair Value Chart

Forza Innovations Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Forza Innovations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Forza Innovations's Peter Lynch Fair Value

For the Medical Devices subindustry, Forza Innovations's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forza Innovations's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Forza Innovations's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Forza Innovations's Price-to-Peter-Lynch-Fair-Value falls into.



Forza Innovations Peter Lynch Fair Value Calculation

Forza Innovations's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.007
=N/A

Forza Innovations's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.01.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Forza Innovations  (OTCPK:FORZ) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Forza Innovations's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.0001/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forza Innovations Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Forza Innovations's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Forza Innovations (Forza Innovations) Business Description

Traded in Other Exchanges
N/A
Address
406 9th Avenue, Suite 210, San Diego, CA, USA, 92101
Forza Innovations Inc is in the health-tech wearable performance business. The company has acquired all the ownership and rights to certain late developmental-stage products, including the J4 Sport, J4 X, and J4 Fitbelt. These products are wearable back compression devices, used to relax, warm up, loosen, or relax stiff & sore muscles. The therapeutic application of heat causes a change in the temperature of the soft tissues which decreases joint stiffness and relieves inflammation.
Executives
Johnny Forzani director, 10 percent owner, officer: Pres., CEO, Sec., Treas., CFO 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Shefali Vibhakar director, 10 percent owner, officer: President, CEO, CFO, Sec. Trea 1914 24TH AVE E, PALMETTO FL 34221
Tom Forzani director 30 FORZANI WAY, CALGARY A0 T3Z 1L5
Geoff Stanbury director BOX 25 SITE 1 RR1, MILLARVILLE A0 T0L 1K0